Diseño del estudio IBEAS: prevalencia de efectos adversos en hospitales de Latinoamérica

Andrés, Jesús María Aranaz; Remón, Carlos Aibar; Limón-Ramírez, Ramón; Amarilla, A.; Restrepo, F. R.; Urroz, O; Sarabia, Odet; Inga, R.; Santivañez, A.; Gonseth-García, J.; Larizgoitia-Jauregui, I.; Varela, Yolanda Agra; Terol-García, Enrique

doi:10.1016/j.cali.2010.12.001

Cited by 40 publications

(37 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the IBEAS project the AE was defined as: 9 ’Any event causing harm to the patient that is perceived to be more related to the healthcare management rather than to the patient’s underlying condition’.…”

Section: Methodsmentioning

confidence: 99%

“…The IBEAS Study was a multicountry effort aiming to estimate for the first time the frequency of hospital related AEs in a selection of hospitals from Argentina, Colombia, Costa Rica, Mexico and Peru. 9 The study was conducted in 2007, in 58 hospitals of the five countries, with the collaboration of Spain, and pan-American organisation and WHO. It used a 1-day cross-sectional design due to the perceived simplicity, lesser demands and greater opportunities for strengthening local capacity and eventual replication of this approach.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

Andrés

Ramírez²,

Remón

et al. 2017

BMJ Open

View full text Add to dashboard Cite

BackgroundAdverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data collection involves a sophisticated sampling plan, and a process of intensive review of sometimes very heavy and complex medical records. Cross-sectional survey is also a valid and feasible methodology to study AEs.ObjectivesThe aim of this study is to compare AEs detection using two different methodologies: cross-sectional versus retrospective cohort design.SettingSecondary and tertiary hospitals in five countries: Argentina, Colombia, Costa Rica, Mexico and Peru.ParticipantsThe IBEAS Study is a cross-sectional survey with a sample size of 11 379 patients. The retrospective cohort study was obtained from a 10% random sample proportional to hospital size from the entire IBEAS Study population.MethodsThis study compares the 1-day prevalence of the AEs obtained in the IBEAS Study with the incidence obtained through the retrospective cohort study.ResultsThe prevalence of patients with AEs was 10.47% (95% CI 9.90 to 11.03) (1191/11 379), while the cumulative incidence of the retrospective cohort study was 19.76% (95% CI 17.35% to 22.17%) (215/1088). In both studies the highest risk of suffering AEs was seen in Intensive Care Unit (ICU) patients. Comorbid patients and patients with medical devices showed higher risk.ConclusionThe retrospective cohort design, although requires more resources, allows to detect more AEs than the cross-sectional design.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

Andrés

Ramírez²,

Remón

et al. 2017

BMJ Open

View full text Add to dashboard Cite

show abstract

“…El equipo de campo fue capacitado y entrenado previamente sobre los procedimientos, instrumentos e instructivos diseñados para la recolección de la información así como para el control de calidad de los datos. La flebitis, variable desenlace, fue definida como la presencia de al menos 2 de los siguientes signos o síntomas al examen del sitio de inserción del catéter periférico: enrojecimiento, hinchazón, cordón venoso se consideraron de moderada gravedad (ocasionan una prolongación de la estancia hospitalaria de al menos 1 día) y el 11,7% de leve gravedad (lesión o complicación que no prolonga la estancia hospitalaria), esta clasificación teniendo en cuenta el concepto de la gravedad del evento adverso del estudio IBEAS (AranazAndrés et al, 2011). Factores relacionados con el desarrollo de flebitis secundaria a cateterismos venoso periférico: en el análisis bivariado se encontró asociación estadísticamente significativa con la edad (p=0,007), la duración de la estancia en el hospital (p=0,003), el recuento de plaquetas (p=0,043), el número de medicamentos administrados (p<0,001), la administración de protectores de mucosa o antisecretores gástricos (p=0,041) y el uso de medicamentos antibacterianos (p=0,002).…”

Section: Metodologíaunclassified

Incidence and factors associated with development of phlebitis: results of a pilot study cohort

Rojas-Sánchez¹,

Parra²,

Camargo-Figuera³

2015

Rev. Enf. Ref

View full text Add to dashboard Cite

Resumopp.61-67 Resumen Revista de Enfermagem Referência A R T I G O D E I N V E S T I G A Ç Ã O Incidencia y factores asociados al desarrollo de flebitis: resultados del estudio piloto de una cohorteIncidence and factors associated with development of phlebitis: results of a pilot study cohort Incidência e fatores associados com o desenvolvimento de flebite: resultados do estudo piloto de uma coorte Lyda Zoraya Rojas-Sánchez*; Dora Inés Parra**; Fabio Alberto Camargo-Figuera*** Marco contextual: La terapia intravenosa es uno de los procedimientos más realizados en los hospitales, mientras que la flebitis es la complicación más común en este tipo de tratamiento. Objetivos: Determinar la incidencia y los factores asociados a la flebitis tras la realización de un cateterismo venoso periférico. Metodología: En agosto de 2010, se realizó un estudio piloto para una cohorte prospectiva sobre la frecuencia de flebitis en Bucaramanga (Colombia). El estudio incluyó a 198 personas mayores de 18 años que ingresaron en el servicio de urgencias y que tenían un período de internamiento hospitalario de 6 a 24 horas. Se evaluaron variables sociodemográficas, clínicas y algunos posibles factores de riesgo para la flebitis. Se realizó un seguimiento de los participantes hasta que se les dio el alta hospitalaria, con el objetivo de monitorizar la aparición de flebitis.Resultados: La incidencia acumulada de flebitis fue de 10,1 %. Seis factores de riesgo se asociaron al desarrollo de flebitis tras la realización del cateterismo venoso periférico. Conclusión: Se aportan evidencias para algunos de los factores de riesgo de flebitis que se pueden utilizar para que el enfermero pueda realizar una identificación e intervención temprana.Palabras clave: flebitis; incidencia; factores de riesgo; seguridad del paciente.Enquadramento: A terapia intravenosa é um dos procedi mentos mais realizados na prática hospitalar; sendo a flebite a complicação mais comum neste tipo de tratamento. Objetivos: Determinar a incidência e os fatores associados à flebite póscateterismo venoso periférico. Metodologia: Foi realizado um estudo piloto para uma coorte prospectiva, em agosto de 2010, sobre a frequência de flebite em Bucaramanga, Colômbia. O estudo incluiu 198 pessoas com mais de 18 anos admitidas na sala de emergência hospitalar e com período de internamento entre 624 horas. Foram avaliadas variáveis sociodemográficas, clínicas e alguns potenciais fatores de risco para flebite. Os participantes foram seguidos até a alta hospitalar para que fosse possível monitorar a ocorrência de flebite. Resultados: A incidência cumulativa de flebite foi de 10,1%. Seis fatores de risco foram associados com o desenvolvimento de flebite secundária à cateterização venosa periférica. Conclusão: Evidência é fornecida para alguns dos fatores de risco de flebite que podem ser utilizados na identificação e intervenção precoce pelo enfermeiro.Palavras-chave:: flebite; incidência; fatores de risco; segurança do paciente.Theoretical framework: Intravenous therapy is on...

show abstract

“…Primum non nocere (first, to do no harm) is a basic concept in healthcare. Numerous worldwide studies conducted since the year 2000 show how patients may be harmed as a result of healthcare attention with an important percentage of preventability [9]. A learning curve makes reference to a period of time an individual takes to learn a subject or specific skill.…”

Section: Education-based Simulation and Definitionsmentioning

confidence: 99%

Simulation: A Training Resource for Quality Care and Improving Patient Safety

Escudero¹,

Silva²,

Corvetto³

2020

Nursing - New Perspectives

View full text Add to dashboard Cite

Patient safety is an ever-present topic in the discussion of educators. It has been 20 years since the publication of To Err Is Human, and there are lessons learned, although there is still much to be done. Healthcare systems are becoming increasingly complex, putting the safety of patients at risk. In this context, there is a greater exposure of healthcare professionals to medical-legal liability issues and to becoming victims of situations that are often preventable. Nurses and medical doctors are especially exposed to these situations, since they are visible during procedures, or do so during the points of greater risk during the patient care process. This chapter will review the contribution provided by the curricular integration of simulation-based education as a tool to train technical and nontechnical issues and how this work can be done for the safety of patients through a standardized training plan, under controlled and evaluated processes. We will discuss how resources and elements allow to perform healthcare interventions in a more safely manner. Finally, we will review the existing literature, some experiences, and the available evidence on this topic.

show abstract

Diseño del estudio IBEAS: prevalencia de efectos adversos en hospitales de Latinoamérica

Cited by 40 publications

References 17 publications

Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

Incidence and factors associated with development of phlebitis: results of a pilot study cohort

Simulation: A Training Resource for Quality Care and Improving Patient Safety

Contact Info

Product

Resources

About